Role of anti-β 2 glycoprotein 1 antibodies in ESRD patients with antiphospholipid antibody syndrome

Clinical Transplantation

Volumn 16, Issue 5, 2002, Pages 362-367

  Vaidya, S ^a   Daller, J ^a   Gugliuzza, K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; PHOSPHOLIPID;

ADULT; ANTIBODY TITER; ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING DISORDER; CADAVER KIDNEY; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPOTHESIS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; SPONTANEOUS ABORTION; THROMBOSIS; VASCULAR DISEASE;

ADULT; ANTIBODIES; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; FEMALE; GLYCOPROTEINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED;

EID: 0036786064     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2002.02024.x     Document Type: Article

References (33)

1. Bowie EF, Thompson JH, Pascuzzi CA. Thrombosis in systemic lupus erythematosus despite circulating lupus anticoagulant. J Laboratory Clin Med 1963: 62: 416.
2. Bell WR, Boss GR, Wolfson JS. Circulatin anticoagulant in the procainamide-induced lupus syndrome. Arch Intern Med 1977: 137: 1471.
3. Bick RL. Circulating anticoagulants. In Bick RL, ed. Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice. Chicago: ASCP Press, 1992: 223.
4. Espinoza RL, Hartman RC. Significance of lupus anticoagulant. Am J Hematol 1986: 22: 331.
5. Shapiro SS, Thagarajan P. Lupus anticoagulants. Prog Hemostas Thromb 1982: 6: 263.
6. Zarraki MH, Zucker S, Miller F. Immunologic and coagulation disorders in chlorpromazine treated patients. Ann Intern Med 1979: 91: 94.
7. Roubey RAS. Auto-antibodies to phospholipid bind prasma proteins. a new view of lupus anticoagulant and other 'antiphospholipid' auto-antibodies. Blood 1994: 84: 2854.
8. Wilson AW, Gharavi AE, Takao K et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheumatism 1999: 7: 1309.
9. Brunet P, Aillaud MF, San Marco M et al. Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis. Int Soc Nephrol 1995: 794.
10. Mandreoli M, Zucchelli P. Renal vascular disease in patients with primary antiphospholipid antibodies. Nephrol Dial Transplant 1993: 8: 1277.
11. Garcia-Martin F, Dearriba G, Carrascosa F et al. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dial Transplant 1991: 6: 543.
12. Amigo MC, Garcia-Torres R, Robles M et al. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992: 19: 1181.
13. Knight RJ, Schanzer H, Rand JH, Burrows L. Renal allograft thrombosis associated with the antiphospholipid antibody syndrome. Transplantation 1995: 60: 614.
14. Mondragon-Rameriz G, Bochicchio T, Garcia-Torres R et al. Recurrent renal thrombotic angiopathy after kidney transplantation in two patients with primary antiphospholipid antibody syndrome (PAPS). Clin Transplant 1994: 8: 13.
15. Vaidya S, Wang CC, Gugliuzza K, Fish JC. Relative risk of post transplant renal thrombosis in patients with antiphospholipid antibodies. Clin Transplant 1998: 12: 439.
16. Vaidya S, Sellers R, Kimball P et al. Frequency potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome. Transplantation 2000: 69: 1348.
17. Vaidya S, Wang C, Gugliuzza K, Fish JC. Antiphospholipid antibody syndrome and post-transplant renal thrombosis. Transpl Proc 1999: 31: 230.
18. 2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995: 89: 397.
19. 2 glycoprotein I (apolipoprotein H). PNAS 1990: 87: 4120.
20. 2-glycoprotein I. A plasma inhibitor of contact activation of the intrinsic blood coagulation pathway. Blood 1985: 66: 1086.
21. Guerin J, Feighery C, Sim RB, Jackson J. Antibodies to (beta) 2-glycoprotein I - a specific marker for the antiphospholipid antibody syndrome. Clin Exp Immunol 1997: 109: 304.
22. Kandiah DA, Krilis SA. Beta2 - glycoprotein I. Lupus 1994: 3: 207.
23. Zhu M, Olee T, Le D et al. Characterization of IgG monoglonal anti-cardiolipin/anti-beta2 GP1 antibodies from two patients with antiphospholipia syndrome reveals three species of antibodies. Br J Haematol 1999: 105: 102.
24. 2-glycoprotein - 1 than with antiphospholipid antibodies. J Rheumatol 1995: 22: 1899.
25. Galli M, Comfurius P, Maasson C. et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma cofactor. Lancet 1990: 335: 1544.
26. Matsuura E, Igarashi Y, Nagae H et al. Anticardiolipin cofactor (s) and differential diagnosis of auto immune disease. Lancet 1990: 336: 177.
27. 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in auto immune disease but not with infection. Lupus 1992: 1: 75.
28. 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992: 93: 181.
29. 2 - glycoprotein I and antiprothrombin antibodies on anticoagulation activity of activated protein C. Blood 1998: 91: 1999.
30. Malia RG, Kitchen S, Greaves M, Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 1990: 76: 101.
31. Marciniak E, Romond EH. Impaired catalytic function of activated protein C. a new in-vitro manifestation of lupus anticoagulant. Blood 1989: 74: 2426.
32. Oosting JD, Derksen RH, Bobbink WM et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: an explanation for their pathogenic mechanism? Blood 1993: 81: 2618.
33. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for diagnosis of lupus anticoagulant: an update. Thrombo Haemost 1995: 74: 1185.